デフォルト表紙
市場調査レポート
商品コード
1578828

薬局給付管理ソフトウェア市場:タイプ、事業者、エンドユーザー、展開別-2025-2030年世界予測

Pharmacy Benefit Manager Software Market by Type (Integrated, Standalone), Operataion (Benefit Plan Design & Consultation, Drug Formulary Management, Retail Pharmacy Services), End-User, Deployment - Global Forecast 2025-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
薬局給付管理ソフトウェア市場:タイプ、事業者、エンドユーザー、展開別-2025-2030年世界予測
出版日: 2024年10月29日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

薬局給付管理ソフトウェア市場の2023年の市場規模は16億6,000万米ドルで、2024年には19億米ドルに達すると予測され、CAGR 14.61%で成長し、2030年には43億3,000万米ドルに達すると予測されています。

薬局給付管理(PBM)ソフトウェアは、処方薬給付の管理を最適化することで、ヘルスケア業界で極めて重要な役割を果たしています。PBMソフトウェアには、処方薬請求の処理と支払い、処方箋の作成と管理、薬局との契約などのツールが含まれます。PBMソフトウェアの必要性は、大量の処方箋データを管理する複雑さと規模、そして費用対効果の高い薬剤管理ソリューションの需要に起因しています。PBMソフトウェアの用途は、保険会社、雇用主、および収益性と規制遵守を維持しながら手頃な価格の医薬品を提供することを目的とするその他のプランスポンサーに及びます。最終用途としては、業務の合理化と患者の転帰の改善を目指すヘルスケアシステム、薬局小売業者、保険会社などが一般的です。

主な市場の統計
基準年[2023] 16億6,000万米ドル
予測年[2024] 19億米ドル
予測年[2030] 43億3,000万米ドル
CAGR(%) 14.61%

主な成長要因としては、コストの透明性に対する要求の高まり、長期にわたる薬物療法を必要とする慢性疾患の増加、ヘルスケアコスト管理に対する政府の圧力などが挙げられます。PBMソフトウェアにおけるAIと機械学習の出現は、高度な予測分析と個別化された投薬管理を可能にし、意思決定の改善とコスト削減を促進することで、潜在的な機会を提供します。しかし、データ・プライバシーの懸念、既存のヘルスケア・システムとの統合の課題、市場統合の可能性が競争を制約するなどの制約が大きな課題となっています。

イノベーションが必要な分野には、医療記録との相互運用性の強化や、安全で透明性の高い医薬品サプライチェーンのためのブロックチェーンの導入などがあります。遠隔医療サービスとシームレスに統合するプラットフォームの開発に注力することで、遠隔ヘルスケア管理を志向する消費者の動向に対応できると思われます。同市場は、急速な技術進歩、規制の変化、消費者の期待の進化を特徴としており、市場プレーヤーにとって俊敏性と適応性が不可欠となっています。チャンスを生かすために、企業はAI統合のための研究開発に投資し、戦略的提携を結んでサービス提供を拡大し、信頼構築とユーザー満足度向上のための顧客サービス強化に注力すべきです。全体として、成長の可能性は大きいが、この市場をうまく立ち回れるかどうかは、規制上の懸念に対処し、強固なデータ・セキュリティ対策を維持できるかどうかにかかっています。

市場力学:急速に進化する薬局給付管理ソフトウェア市場の主要市場インサイトを公開

薬局給付管理ソフトウェア市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 薬剤使用に伴う健康リスクを回避し、患者の安全性を向上させる必要性
    • 薬剤処方の理由付けと薬剤製剤の適応の遵守を向上させる。
    • 投薬管理を改善するための科学的根拠を提供することで、医療専門家をサポートする必要性
  • 市場抑制要因
    • リベート削減のための厳しい規制
  • 市場機会
    • 製薬メーカーとのバリューベース契約の増加
    • 大手eコマースベンダーの薬局流通と償還市場
  • 市場の課題
    • PBM業界を取り巻く法的不確実性

ポーターの5つの力:薬局給付管理ソフトウェア市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:薬局給付管理ソフトウェア市場における外部からの影響の把握

外部マクロ環境要因は、薬局給付管理ソフトウェア市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析薬局給付管理ソフトウェア市場における競合情勢の把握

薬局給付管理ソフトウェア市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス薬局給付管理ソフトウェア市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、薬局給付管理ソフトウェア市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨薬局給付管理ソフトウェア市場における成功への道筋を描く

薬局給付管理ソフトウェア市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品上市、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 薬剤使用に伴う健康リスクを回避することで患者の安全性を向上させる必要がある
      • 薬剤処方の推論と薬剤処方の適応の遵守を改善する
      • 投薬管理を改善するための科学的証拠を提供することで医療専門家を支援する必要がある
    • 抑制要因
      • 割引を削減するための厳しい規制
    • 機会
      • 医薬品メーカーとの価値ベースの契約の増加
      • 大手eコマースベンダーの薬局流通および償還市場
    • 課題
      • PBM業界を取り巻く法的な不確実性
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 薬局給付管理ソフトウェア市場:タイプ別

  • 統合型
  • スタンドアロン

第7章 薬局給付管理ソフトウェア市場オペレーション

  • 福利厚生プランの設計とコンサルティング
  • 医薬品処方管理
  • 小売薬局サービス
  • 専門薬局サービス

第8章 薬局給付管理ソフトウェア市場:エンドユーザー別

  • 政府
  • 保険会社
  • 患者
  • 薬局

第9章 薬局給付管理ソフトウェア市場:展開別

  • クラウド上
  • オンプレミス

第10章 南北アメリカの薬局給付管理ソフトウェア市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の薬局給付管理ソフトウェア市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの薬局給付管理ソフトウェア市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Anthem Insurance Companies, Inc.
  • Benecard Services, LLC
  • BioScrip, Inc.
  • Cachet Pharmaceuticals Private Limited
  • CaptureRx
  • Change Healthcare, Inc.
  • CVS Health Corporation
  • Elixir Rx Solutions LLC
  • Express Scripts Holding Company
  • HUB International Limited
  • Magellan Health, Inc.
  • MedImpact Healthcare Systems, Inc.
  • Prime Therapeutics LLC
  • Rite Aid Corporation
  • SS&C Technologies Holdings, Inc.
  • UnitedHealth Group Incorporated
図表

LIST OF FIGURES

  • FIGURE 1. PHARMACY BENEFIT MANAGER SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHARMACY BENEFIT MANAGER SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHARMACY BENEFIT MANAGER SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACY BENEFIT MANAGER SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACY BENEFIT MANAGER SOFTWARE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY BENEFIT PLAN DESIGN & CONSULTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DRUG FORMULARY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY RETAIL PHARMACY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY SPECIALTY PHARMACY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY INSURANCE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY PATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY OPERATAION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PHARMACY BENEFIT MANAGER SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 191. PHARMACY BENEFIT MANAGER SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. PHARMACY BENEFIT MANAGER SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-4360E5D63296

The Pharmacy Benefit Manager Software Market was valued at USD 1.66 billion in 2023, expected to reach USD 1.90 billion in 2024, and is projected to grow at a CAGR of 14.61%, to USD 4.33 billion by 2030.

Pharmacy Benefit Manager (PBM) Software plays a pivotal role in the healthcare industry by optimizing the management of prescription drug benefits. It encompasses tools for processing and paying prescription drug claims, developing and maintaining formularies, and contracting with pharmacies. The necessity for PBM software stem from the complexity and scale of managing large volumes of prescription data and the demand for cost-effective drug management solutions. Its application spans across insurance companies, employers, and other plan sponsors who aim to provide affordable medications while maintaining profitability and regulatory compliance. End-use typically includes healthcare systems, pharmacy retailers, and insurers who seek to streamline operations and improve patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 1.66 billion
Estimated Year [2024] USD 1.90 billion
Forecast Year [2030] USD 4.33 billion
CAGR (%) 14.61%

Key growth factors include the increasing demand for cost transparency, the rise in chronic diseases requiring prolonged drug therapy, and governmental pressures for healthcare cost control. The emergence of AI and machine learning in PBM software offers potential opportunities by enabling advanced predictive analytics and personalized medication management, fostering improved decision-making, and cost savings. However, limitations such as data privacy concerns, integration challenges with existing healthcare systems, and the potential for market consolidation constraining competition pose significant challenges.

Areas ripe for innovation include enhancing interoperability with medical records and implementing blockchain for secure and transparent drug supply chains. Focusing on developing platforms that integrate seamlessly with telemedicine services could address consumer trends leaning toward remote healthcare management. The market is characterized by rapid technological advancements, regulatory shifts, and evolving consumer expectations, making agility and adaptability essential for market players. To capitalize on opportunities, firms should invest in R&D for AI integration, form strategic alliances to expand service offerings, and focus on enhancing customer service to build trust and improve user satisfaction. Overall, while the potential for growth is significant, successful navigation of this market will depend on addressing regulatory concerns and maintaining robust data security measures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmacy Benefit Manager Software Market

The Pharmacy Benefit Manager Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need to improves patient's safety by avoiding the health risks associated with medication use
    • Improves the adherence to drug prescription reasoning and adaptation of drug formulations
    • Need to supports health professionals by providing the scientific evidence to improve the medication management
  • Market Restraints
    • Stringent regulations to cut back rebates
  • Market Opportunities
    • Rise in Value-based contracts with Pharma manufacturers
    • Big e-commerce vendors pharmacy distribution and reimbursement market
  • Market Challenges
    • Legal uncertainty surrounds the PBM industry

Porter's Five Forces: A Strategic Tool for Navigating the Pharmacy Benefit Manager Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmacy Benefit Manager Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmacy Benefit Manager Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmacy Benefit Manager Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmacy Benefit Manager Software Market

A detailed market share analysis in the Pharmacy Benefit Manager Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmacy Benefit Manager Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmacy Benefit Manager Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmacy Benefit Manager Software Market

A strategic analysis of the Pharmacy Benefit Manager Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmacy Benefit Manager Software Market, highlighting leading vendors and their innovative profiles. These include Anthem Insurance Companies, Inc., Benecard Services, LLC, BioScrip, Inc., Cachet Pharmaceuticals Private Limited, CaptureRx, Change Healthcare, Inc., CVS Health Corporation, Elixir Rx Solutions LLC, Express Scripts Holding Company, HUB International Limited, Magellan Health, Inc., MedImpact Healthcare Systems, Inc., Prime Therapeutics LLC, Rite Aid Corporation, SS&C Technologies Holdings, Inc., and UnitedHealth Group Incorporated.

Market Segmentation & Coverage

This research report categorizes the Pharmacy Benefit Manager Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Integrated and Standalone.
  • Based on Operataion, market is studied across Benefit Plan Design & Consultation, Drug Formulary Management, Retail Pharmacy Services, and Specialty Pharmacy Services.
  • Based on End-User, market is studied across Government, Insurance Providers, Patient, and Pharmacy.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to improves patient's safety by avoiding the health risks associated with medication use
      • 5.1.1.2. Improves the adherence to drug prescription reasoning and adaptation of drug formulations
      • 5.1.1.3. Need to supports health professionals by providing the scientific evidence to improve the medication management
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations to cut back rebates
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in Value-based contracts with Pharma manufacturers
      • 5.1.3.2. Big e-commerce vendors pharmacy distribution and reimbursement market
    • 5.1.4. Challenges
      • 5.1.4.1. Legal uncertainty surrounds the PBM industry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmacy Benefit Manager Software Market, by Type

  • 6.1. Introduction
  • 6.2. Integrated
  • 6.3. Standalone

7. Pharmacy Benefit Manager Software Market, by Operataion

  • 7.1. Introduction
  • 7.2. Benefit Plan Design & Consultation
  • 7.3. Drug Formulary Management
  • 7.4. Retail Pharmacy Services
  • 7.5. Specialty Pharmacy Services

8. Pharmacy Benefit Manager Software Market, by End-User

  • 8.1. Introduction
  • 8.2. Government
  • 8.3. Insurance Providers
  • 8.4. Patient
  • 8.5. Pharmacy

9. Pharmacy Benefit Manager Software Market, by Deployment

  • 9.1. Introduction
  • 9.2. On-Cloud
  • 9.3. On-Premise

10. Americas Pharmacy Benefit Manager Software Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmacy Benefit Manager Software Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmacy Benefit Manager Software Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anthem Insurance Companies, Inc.
  • 2. Benecard Services, LLC
  • 3. BioScrip, Inc.
  • 4. Cachet Pharmaceuticals Private Limited
  • 5. CaptureRx
  • 6. Change Healthcare, Inc.
  • 7. CVS Health Corporation
  • 8. Elixir Rx Solutions LLC
  • 9. Express Scripts Holding Company
  • 10. HUB International Limited
  • 11. Magellan Health, Inc.
  • 12. MedImpact Healthcare Systems, Inc.
  • 13. Prime Therapeutics LLC
  • 14. Rite Aid Corporation
  • 15. SS&C Technologies Holdings, Inc.
  • 16. UnitedHealth Group Incorporated